Advances in the management of hematological malignancies have significantly improved survival outcomes; however, supportive care remains a critical determinant of treatment tolerance and overall prognosis. Malnutrition is highly prevalent among patients with hematological cancers and is associated with increased treatment-related toxicity, infectious complications, prolonged hospitalization, and reduced quality of life. In Morocco, nutritional management in hematology is frequently under-recognized and inconsistently implemented. Limited availability of specialized clinical nutrition services, insufficient systematic nutritional screening, and the absence of national guidelines contribute to heterogeneous practices across institutions. Moreover, treatment-related gastrointestinal toxicities, prolonged hospital stays, and socioeconomic constraints further exacerbate nutritional deterioration in this vulnerable population. This editorial highlights the current burden of malnutrition among Moroccan patients with hematological malignancies, reviews available national data, and discusses organizational and structural barriers to optimal nutritional care. Addressing these gaps through early nutritional assessment, multidisciplinary collaboration, and the integration of standardized nutritional protocols is essential to improve treatment tolerance, clinical outcomes, and equity of supportive care in hematology in Morocco.
Ouafa et al. (Wed,) studied this question.